- Vigil Health Solutions has received approval from the TSE to renew its normal course issuer bid
- Between September 30, 2021, and September 29, 2022, Vigil Health may purchase for cancellation up to 900,000 common shares
- Vigil offers a technology platform combining software and hardware to support the seniors’ housing market
- Vigil Health Solutions Inc. (VGL) is down 7.58 per cent, trading at C$0.61 per share at 12 pm ET
Vigil Health Solutions (VGL) has received approval from the TSE to renew its normal course issuer bid.
Between September 30, 2021, and September 29, 2022, Vigil Health may purchase for cancellation up to 900,000 common shares representing approximately 4.96 per cent of the company’s issued and outstanding common shares. A purchase of common shares under the bid may not exceed 2 per cent of the outstanding common shares at that time.
In the opinion of its board of directors, the market price of Vigil Health’s common shares may not fully reflect the underlying value of its operations and future growth prospects. The purchase and cancellation of common shares may represent an appropriate and desirable use of the company’s funds.
Under the company’s current normal course issuer bid which expires on September 29, 2021, Vigil Health has purchased for cancellation 59,500 common shares at an average price of $0.34 per share for a total cost of $19,992.50.
Vigil offers a technology platform combining software and hardware to provide solutions to the expanding seniors’ housing market. Vigil’s product range includes the innovative wireless Vitality Care System™ featuring discreet ‘mini pendants’, a nurse call system, mobile fall/incontinence monitoring, resident check-in and the award-winning Vigil Dementia System.
Vigil Health Solutions Inc. (VGL) is down 7.58 per cent, trading at C$0.61 per share at 12 pm ET.
